Back to search
FDAFDA · Food and drugs·Recall number D-1443-2012

Meloxicam Tablets, USP, 15 mg, Rx Only, 100 Tablets per Bottle, Manufactured by: Strides Acrolab Ltd., Bangalore-560 076, India, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-3579-1.

Published August 15, 2012 · Recall initiated: April 5, 2012

Summary

FDA records drug Class II recall D-1443-2012, published August 15, 2012 and initiated April 5, 2012. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 1,749 Bottles; Lot: Lot: 7212558, Exp 12/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Corp.
Distributor
Nationwide
Lot
Lot: 7212558, Exp 12/12.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Meloxicam Tablets, USP, 15 mg, Rx Only, 100 Tablets per Bottle, Manufactured by: Strides Acrolab Ltd., Bangalore-560 076, India, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-3579-1. recalled?

Yes. FDA published recall D-1443-2012 on August 15, 2012. Reported hazard: Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.

What should I do if I have this product?

Voluntary: Firm initiated · Letter